Evidence map›Paper›PMID 39177021›Full record

ArticleeLife2024

Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II.

Raphael Vidal, Eoin Leen, Steffi Herold, Mareike Müller, Daniel Fleischhauer, Christina Schülein-Völk, Dimitrios Papadopoulos, Isabelle Röschert, Leonie Uhl, Carsten P Ade and 4 more

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Raphael VidalTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.
Eoin LeenAstbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
Steffi HeroldTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.
Mareike MüllerTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.
Daniel FleischhauerTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.
Christina Schülein-VölkTheodor Boveri Institute, Core Unit High-Content Microscopy, Biocenter, University of Würzburg, Würzburg, Germany.
Dimitrios PapadopoulosTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.ORCID https://orcid.org/0000-0002-3415-7407
Isabelle RöschertTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.
Leonie UhlTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.
Carsten P AdeTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.ORCID https://orcid.org/0000-0001-7226-1179
Peter GallantTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.
Richard BaylissAstbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.ORCID https://orcid.org/0000-0003-0604-2773
Martin EilersTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.ORCID https://orcid.org/0000-0002-0376-6533
Gabriele BüchelTheodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany.ORCID https://orcid.org/0000-0001-7070-7341

Funding

Alex's Lemonade Stand Foundation for Childhood Cancer Crazy 8 InitiativeDeutsche Forschungsgemeinschaft INST 93/1023-1-FUGG and EI222/21-1Deutsche Krebshilfe 70113303Deutsche Krebshilfe 70113870Medical Research Council MR/V029975/1Wilhelm Sander-Stiftung 2023.002.1
6 · The paper itself

Abstract

MYC family oncoproteins regulate the expression of a large number of genes and broadly stimulate elongation by RNA polymerase II (RNAPII). While the factors that control the chromatin association of MYC proteins are well understood, much less is known about how interacting proteins mediate MYC's effects on transcription. Here, we show that TFIIIC, an architectural protein complex that controls the three-dimensional chromatin organisation at its target sites, binds directly to the amino-terminal transcriptional regulatory domain of MYCN. Surprisingly, TFIIIC has no discernible role in MYCN-dependent gene expression and transcription elongation. Instead, MYCN and TFIIIC preferentially bind to promoters with paused RNAPII and globally limit the accumulation of non-phosphorylated RNAPII at promoters. Consistent with its ubiquitous role in transcription, MYCN broadly participates in hubs of active promoters. Depletion of TFIIIC further increases MYCN localisation to these hubs. This increase correlates with a failure of the nuclear exosome and BRCA1, both of which are involved in nascent RNA degradation, to localise to active promoters. Our data suggest that MYCN and TFIIIC exert an censoring function in early transcription that limits promoter accumulation of inactive RNAPII and facilitates promoter-proximal degradation of nascent RNA.

Indexed as

ChromatinN-Myc Proto-Oncogene ProteinPromoter Regions, GeneticRNA Polymerase IICell Line, TumorHumansProtein BindingTranscription Factors, TFIITranscription, GeneticChromatinMYCN protein, humanN-Myc Proto-Oncogene ProteinRNA Polymerase IITranscription Factors, TFIIcancer biologychromosomesgene expressionhumanMYCNneuroblastomanuclear exosomepromoter hubTFIIIC

Identifiers

PMID39177021
PMCPMC11343564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.